Diabetes Mellitus and Mortality among COVID-19 Patients in Jakarta, March-August 2020

Endang Widuri Wulandari, Sudarto Rotnoatmodjo, Ngabila Salama


Diabetes mellitus (DM) comorbidity is one of the risk factors for coronavirus disease 2019 (COVID-19) mortality. This study aimed to determine the association of comorbid DM and mortality among COVID-19 confirmed cases in DKI Jakarta Province, controlled with confounding variables from March to August 2020. The study design was a retrospective cohort using cox proportional hazard regression, with a total sample of 1,480. The data consisted of 740 COVID-19 cases with and 740 without comorbid DM. The inclusion criteria were COVID-19 confirmed cases with polymerase chain reaction (PCR) laboratory testing reported to the DKI Jakarta Provincial Department of Health, and the exclusion criteria were pregnant women. The study result indicated that the Crude Hazard Ratio (CHR) of DM and mortality among COVID-19 confirmed cases was 7.4 (95% CI = 4.5-12.3, p-value<0.001), while the adjusted Hazard Ratio, controlled by covariates (comorbid hypertension and age groups) was 3.9 (95% CI = 2.2- 6.8, p-value<0.001). This concludes that the risk of death from COVID-19 cases with comorbid DM was 3.9 times compared to those without comorbid DM after controlling for confounding variables comorbid hypertension and age group (<50 years and >50 years).


diabetes mellitus, COVID-19, DKI Jakarta, mortality

Full Text:



 1. Gates B. Responding to COVID-19 — A once-in-a-century pandemic? N Engl J Med. 2020; 382: 1677-1679.

 2. Mckibbin W, Fernando R. The global macroeconomic impacts of COVID-19: seven scenarios. Asian Economic Papers. 2021; 20 (2): 1-30.

 3. Kandel N, Chungong S, Omaar A, Xing J. Review of health security capacities in light of 2019-nCoV outbreak – opportunities for strengthening IHR (2005) implementation. SSRN eLibrary; 2020.

 4. Global Preparedness Monitoring Board. A world at risk; 2019.

 5. Djalante R, Lassa J, Setiamarga D, Sudjatma A, Indrawan M, Haryanto B, et al. Review and analysis of current responses toCOVID-19 in Indonesia: period of January to March 2020. Prog Disaster Sci. 2020; 6: 1-9.

 6. World Health Organization. COVID-19 weekly epidemiological - update 23 February 2021; 2021.

 7. Hu Y, Sun J, Dai Z, Deng H, Lin X, Huang Q, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020; 127: 104371.

 8. Zhu L, She Z-G, Cheng X, Qin J-J, Zhang X-J, Cai J, et al. Association of blood glucose control and outcomes in patients with covid-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31 (6): 1068-1077.

 9. Singh AK, Gupta R, Misra A. Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr Clin Res Rev. 2020; 14 (4): 283-287.

 10. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr Clin Res Rev. 2020; 14 (4):395-403.

 11. World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19); 2020.

 12. Kementerian Kesehatan Republik Indonesia. Hasil utama riset kesehatan dasar tahun 2018. Kementrian Kesehat Republik Indones; 2018.

 13. Gugus Penanganan COVID-19. Peta sebaran COVID-19. Gugus Tugas Percepatan Penanganan COVID 19; 2020.

 14. Harbuwono DS, Handayani DOTL, Wahyuningsih ES, Supraptowati N, Ananda, Kurniawan F, et al. Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry. Prim Care Diabetes. 2022; 16 (1): 65-68.

 15. Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. J Community Empower Heal. 2020; 3 (2): 77-84.

 16. Muniyappa R, Gubbi S. COVID-19 Pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020; 318: 736-741.

 17. DKI Jakarta Provincial Health Officer. COVID-19 data reporting, March-August 2021.

 18. Rothman KJ. Epidemiology: an Introduction. 2nd ed. New York: Oxford University Press; 2012.

 19. Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, et al. Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study. Diabetes Res Clin Pract. 2020; 165: 108227.

 20. Surendra H, Elyazar IRF, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study. The Lancet Regional Health - Western Pacific. 2021; 9: 1-9.

 21. Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Ghani MA, et al. Impact of diabetes in patients diagnosed with COVID-19. Front Immunol. 2020; 11.

 22. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care. 2007; 30 (9):2251-7.

 23. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Coronavirus. J Virol. 2020; 94 (7).

 24. Satria RMA, Tutupoho RV, Chalidyanto D. Analisis faktor risiko kematian dengan penyakit komorbid Covid-19. J Keperawatan Silampari. 2020; 4 (1): 48-55.

 25. Shang J, Wang Q, Zhang H, Wang X, Wan J, Yan Y, et al. The relationship between diabetes mellitus and covid-19 prognosis: a retrospective cohort study in Wuhan, China. Am J Med. 2021; 134 (1): e6-e14.

 26. Byeon KH, Kim DW, Kim J, Choi BY, Choi B, Cho KD. Factors affecting the survival of early COVID-19 patients in South Korea: an observational study based on the Korean National Health Insurance big data. Int J Infect Dis. 2021; 105: 588-594.

 27. Kun’ain UIA, Rahardjo SS, Tamtomo DG. Meta-analysis: the effect of diabetes mellitus comorbidity on the risk of death in Covid-19 patients. Indones J Med. 2020; 5 (4): 368-377.

 28. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020; 180(10): 1345-1355.

 29. Kshanti IA, Aji G, Eprilliawati M, Mokoagow Md-I, Nasarudin J, Magfira N, et al. Clinical presentation and outcome of covid-19 infection in type 2 diabetes mellitus: a preliminary data from a tertiary hospital in Jakarta during the early days of the pandemic. Bali Med J. 2020; 9 (3): 663-669.

 30. Ganesan SK, Venkatratnam P, Mahendra J, Devarajan N. Increased mortality of COVID-19 infected diabetes patients: role of furin proteases. Int J Obes. 2020; 44: 2486–2488.

 31. Huang J, Zhu L, Bai X, Jia X, Lu Y, Deng A, et al. Multidimensional analysis of risk factors for the severity and mortality of patients with COVID-19 and diabetes. Infect Dis Ther. 2020; 9 (4):981-1002.

 32. Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020; 12 (12): 895-908.

 33. Giovannelli J, Trouiller P, Hulo S, Cherot-Kornobis N, Ciuchete A, Edme J-L, et al. Low-grade systemic inflammation: a partial mediator of the relationship between diabetes and lung function. Ann Epidemiol. 2018; 28 (1):26-32.

 34. Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020; 16: 297-298.

 35. Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. 2009; 302 (2): 193-202.

 36. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in an NF-kB-dependent fashion. J Clin Invest; 1998.

 37. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020; 127: 104354.

 38. Guan WJ, Liang WH, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1,590 patients with COVID-19 inChina: a nationwide analysis. MedRxiv; 2020.

 39. Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020; 23 (5): 1416-1424 .

 40. Kandi V, Thungaturthi S, Vadakedath S, Gundu R, Mohapatra RK. Mortality rates of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Cureus. 2021; 13 (3): e14081.

 41. Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020; 52 (2): 154-164.

 42. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010; 16 (5): 238-246.

DOI: http://dx.doi.org/10.21109/kesmas.v17i2.5815


  • There are currently no refbacks.